ALDH1A2 and breast carcinoma: Reduced protein levels of recombinant aldehyde dehydrogenase 1 family, member A2 (ALDH1A2), a key player in the retinoic acid (RA) pathway and retinoid metabolism, have been reported in human prostate and breast cancer.